Frank Karbe's Net Worth
Frank Karbe's net worth is estimated to be at least $1,906,693.28 as of 11/23/2024. CoreStreet's estimation of Frank Karbe's net worth is based on their sale of stock and current holding of stock.
Frank Karbe is CEO at Better Therapeutics Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 137,005 units of BTTX stock on 07/27/2023. Their biggest sale was on 08/31/2020 when they sold 24,800 units of Myovant Sciences Ltd stock for $496,496.00. They typically trade 2 times per year.
Total value of insider buys:
- $476,101.33
Total value of insider sells:
- $1,430,591.95
Most recent insider trade:
- July 27, 2023
Frank Karbe's Insider Trading History
Better Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
July 27, 2023 | CEO | 137,005 | $0.73 | Buy | $100,013.65 |
April 10, 2023 | Insider | 242,424 | $0.82 | Buy | $198,787.68 |
Sept. 15, 2022 | Insider | 50,000 | $2.09 | Buy | $104,500.00 |
Myovant Sciences Ltd | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
April 6, 2021 | Insider | 11,080 | $18.63 | Sell | $206,420.40 |
Jan. 28, 2021 | Insider | 300 | $24.00 | Sell | $7,200.00 |
Jan. 15, 2021 | Insider | 750 | $21.50 | Sell | $16,125.00 |
Dec. 28, 2020 | Insider | 11,800 | $30.00 | Sell | $354,000.00 |
Nov. 17, 2020 | Insider | 750 | $20.00 | Sell | $15,000.00 |
Nov. 13, 2020 | Insider | 750 | $20.00 | Sell | $15,000.00 |
Aug. 31, 2020 | Insider | 24,800 | $20.02 | Sell | $496,496.00 |
Aug. 19, 2020 | Insider | 700 | $20.00 | Sell | $14,000.00 |
Dec. 30, 2019 | Insider | 19,701 | $15.55 | Sell | $306,350.55 |
June 11, 2019 | Insider | 8,000 | $9.10 | Buy | $72,800.00 |